183 related articles for article (PubMed ID: 37067542)
1. The contribution of N-terminal truncated cMyBPC to in vivo cardiac function.
Dominic KL; Choi J; Holmes JB; Singh M; Majcher MJ; Stelzer JE
J Gen Physiol; 2023 Jun; 155(6):. PubMed ID: 37067542
[TBL] [Abstract][Full Text] [Related]
2. In vivo cardiac myosin binding protein C gene transfer rescues myofilament contractile dysfunction in cardiac myosin binding protein C null mice.
Merkulov S; Chen X; Chandler MP; Stelzer JE
Circ Heart Fail; 2012 Sep; 5(5):635-44. PubMed ID: 22855556
[TBL] [Abstract][Full Text] [Related]
3. The HCM-causing Y235S cMyBPC mutation accelerates contractile function by altering C1 domain structure.
Doh CY; Li J; Mamidi R; Stelzer JE
Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):661-677. PubMed ID: 30611859
[TBL] [Abstract][Full Text] [Related]
4. AAV9 gene transfer of cMyBPC N-terminal domains ameliorates cardiomyopathy in cMyBPC-deficient mice.
Li J; Mamidi R; Doh CY; Holmes JB; Bharambe N; Ramachandran R; Stelzer JE
JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32750038
[TBL] [Abstract][Full Text] [Related]
5. Cardiac myosin binding protein C insufficiency leads to early onset of mechanical dysfunction.
Desjardins CL; Chen Y; Coulton AT; Hoit BD; Yu X; Stelzer JE
Circ Cardiovasc Imaging; 2012 Jan; 5(1):127-36. PubMed ID: 22157650
[TBL] [Abstract][Full Text] [Related]
6. Impact of the Myosin Modulator Mavacamten on Force Generation and Cross-Bridge Behavior in a Murine Model of Hypercontractility.
Mamidi R; Li J; Doh CY; Verma S; Stelzer JE
J Am Heart Assoc; 2018 Sep; 7(17):e009627. PubMed ID: 30371160
[TBL] [Abstract][Full Text] [Related]
7. Normal cardiac contraction in mice lacking the proline-alanine rich region and C1 domain of cardiac myosin binding protein C.
van Dijk SJ; Witt CC; Harris SP
J Mol Cell Cardiol; 2015 Nov; 88():124-32. PubMed ID: 26455481
[TBL] [Abstract][Full Text] [Related]
8. Molecular effects of the myosin activator omecamtiv mecarbil on contractile properties of skinned myocardium lacking cardiac myosin binding protein-C.
Mamidi R; Gresham KS; Li A; dos Remedios CG; Stelzer JE
J Mol Cell Cardiol; 2015 Aug; 85():262-72. PubMed ID: 26100051
[TBL] [Abstract][Full Text] [Related]
9. cMyBPC phosphorylation modulates the effect of omecamtiv mecarbil on myocardial force generation.
Mamidi R; Holmes JB; Doh CY; Dominic KL; Madugula N; Stelzer JE
J Gen Physiol; 2021 Jul; 153(7):. PubMed ID: 33688929
[TBL] [Abstract][Full Text] [Related]
10. Impaired contractile function due to decreased cardiac myosin binding protein C content in the sarcomere.
Cheng Y; Wan X; McElfresh TA; Chen X; Gresham KS; Rosenbaum DS; Chandler MP; Stelzer JE
Am J Physiol Heart Circ Physiol; 2013 Jul; 305(1):H52-65. PubMed ID: 23666674
[TBL] [Abstract][Full Text] [Related]
11. Sarcomeric protein modification during adrenergic stress enhances cross-bridge kinetics and cardiac output.
Gresham KS; Mamidi R; Li J; Kwak H; Stelzer JE
J Appl Physiol (1985); 2017 Mar; 122(3):520-530. PubMed ID: 27909224
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel interactions between domains of Myosin binding protein-C that are modulated by hypertrophic cardiomyopathy missense mutations.
Moolman-Smook J; Flashman E; de Lange W; Li Z; Corfield V; Redwood C; Watkins H
Circ Res; 2002 Oct; 91(8):704-11. PubMed ID: 12386147
[TBL] [Abstract][Full Text] [Related]
13. Myosin binding protein C interaction with actin: characterization and mapping of the binding site.
Rybakova IN; Greaser ML; Moss RL
J Biol Chem; 2011 Jan; 286(3):2008-16. PubMed ID: 21071444
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic properties of the N-terminal region of cardiac myosin binding protein-C in vitro.
Govindan S; Sarkey J; Ji X; Sundaresan NR; Gupta MP; de Tombe PP; Sadayappan S
J Muscle Res Cell Motil; 2012 May; 33(1):17-30. PubMed ID: 22527638
[TBL] [Abstract][Full Text] [Related]
15. Infantile restrictive cardiomyopathy: cTnI-R170G/W impair the interplay of sarcomeric proteins and the integrity of thin filaments.
Cimiotti D; Fujita-Becker S; Möhner D; Smolina N; Budde H; Wies A; Morgenstern L; Gudkova A; Sejersen T; Sjöberg G; Mügge A; Nowaczyk MM; Reusch P; Pfitzer G; Stehle R; Schröder RR; Mannherz HG; Kostareva A; Jaquet K
PLoS One; 2020; 15(3):e0229227. PubMed ID: 32182250
[TBL] [Abstract][Full Text] [Related]
16. Sarcomere-based genetic enhancement of systolic cardiac function in a murine model of dilated cardiomyopathy.
Li J; Gresham KS; Mamidi R; Doh CY; Wan X; Deschenes I; Stelzer JE
Int J Cardiol; 2018 Dec; 273():168-176. PubMed ID: 30279005
[TBL] [Abstract][Full Text] [Related]
17. PKCepsilon increases phosphorylation of the cardiac myosin binding protein C at serine 302 both in vitro and in vivo.
Xiao L; Zhao Q; Du Y; Yuan C; Solaro RJ; Buttrick PM
Biochemistry; 2007 Jun; 46(23):7054-61. PubMed ID: 17503784
[TBL] [Abstract][Full Text] [Related]
18. A Novel "Cut and Paste" Method for In Situ Replacement of cMyBP-C Reveals a New Role for cMyBP-C in the Regulation of Contractile Oscillations.
Napierski NC; Granger K; Langlais PR; Moran HR; Strom J; Touma K; Harris SP
Circ Res; 2020 Mar; 126(6):737-749. PubMed ID: 32078438
[TBL] [Abstract][Full Text] [Related]
19. Cardiac myosin binding protein-C Ser
Mamidi R; Gresham KS; Li J; Stelzer JE
Sci Adv; 2017 Mar; 3(3):e1602445. PubMed ID: 28345052
[TBL] [Abstract][Full Text] [Related]
20. Hypertrophic cardiomyopathy mutations in
Toepfer CN; Wakimoto H; Garfinkel AC; McDonough B; Liao D; Jiang J; Tai AC; Gorham JM; Lunde IG; Lun M; Lynch TL; McNamara JW; Sadayappan S; Redwood CS; Watkins HC; Seidman JG; Seidman CE
Sci Transl Med; 2019 Jan; 11(476):. PubMed ID: 30674652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
